Pulmonary hypertension in polycythemia vera
- 1 November 1994
- journal article
- case report
- Published by Wiley in American Journal of Hematology
- Vol. 47 (3) , 242-244
- https://doi.org/10.1002/ajh.2830470320
Abstract
Thromboembolic events occur in about 27% of the patients with polycythemia vera and account for 31% of the deaths. These include cerebrovascular accidents, myocardial infarction, peripheral vascular occlusions, pulmonary infarctions, and venous thrombosis. We report two cases with polycythemia vera who presented with pulmonary hypertension in the absence of previous thromboembolic complications of any kind. One patient died suddenly, with evidence of extensive bilateral thrombosis of prelobular pulmonary arteries at autopsy. In the second patient, local thrombosis in the pulmonary vasculature or recurrent silent pulmonary emboli appear to be responsible for the development of pulmonary hypertension. After institution of anticoagulant therapy, he is able to maintain his functional status. The purpose of this report is to alert clinicians to the development of this insidious, but potentially fatal complication in patients with polycythemia vera.Keywords
This publication has 4 references indexed in Scilit:
- Cardiac involvement in patients with myeloproliferative disordersThe American Journal of Medicine, 1992
- Increased platelet-fibrinogen affinity in patients with myeloproliferative disorders [see comments]Blood, 1988
- Perfusion lung scanning: differentiation of primary from thromboembolic pulmonary hypertensionAmerican Journal of Roentgenology, 1985
- Complications and Causes of Death in Polycythaemia VeraActa Medica Scandinavica, 1962